Abstract:
A method for the treatment of cancer and pain in an animal subject is disclosed, comprising administering to said animal in need of such treatment an effective amount of a compound of formula (I), wherein R -R are defined herein. Pharmaceutical compositions comprising one or more compounds of formula (I) and a pharmaceutically acceptable carrier are also disclosed.
Abstract:
The invention relates to a compound of the general formula (I) X(B)m, wherein X is a unit of the value m and the members B are the same or different and represent K-R, wherein K represents a bond or A -(A -A )k-sp, wherein A is (CH2)tY(CH2)u, wherein Y is >C=0, >NH, -O-, -S- or a bond, t is an integer from 0 to 6 and u is an integer from 0 to 6, A represents -NHCO-, -CONH-, -OCONH- or SCONH-, or -CO-, A is (CH2)r, O(CH2)r, NH(CH2)r, S(CH2)r, or -(CHQ)-, wherein r is an integer from 1 to 6 and Q is a substituted or unsubstituted alkyl or aryl group, sp represents a bivalent spacer or a bond, and k is an integer from 5 to 100, and R represents hydrogen, a ligand that is suitable to specifically bind to a receptor, a marker molecule or a catalytically active group, and m is at least 2, with the proviso that (1) in the compound at least one R is different from hydrogen, (2) at least 2 K are present that do not represent a bond, and (3) X, the members B and m are selected in such a manner that K can be associated on the intermolecular level in the liquid phase by the formation of hydrogen bonds and the simultaneous formation of aggregate bodies that represent on their surfaces several R that are different from hydrogen, and (4) the molar mass of fragment X(K)m is less than 20.000.
Abstract:
The invention concerns compounds of formulae (Ia) or (Ib) wherein M: represents a molecule for use in the treatment or diagnosis of pathologies affecting the cartilage; R1, R2, R3 represent an alkyl group, or R1, R 2, R3 together with the nitrogen atom which bears them form a heterocycle; X represents a C1-C6 alkyl chain wherein one or several -CH2- groups are optionally substituted by a sulphur, an oxygen atom, a -NR, -CO-, -CO-NH-, -CO2-, SO- or SO2- group; n represents 0 or 1; Hal represents a halogen atom, or the formula (Ib); R4 represents an alkyl group; Hal represents a halogen atom. General formula (F1) represents a molecule for use in the treatment or diagnosis of pathologies affecting the cartilage, provided that the nitrogen atom can optionally be included in a saturated or unsaturated nitrogenous heterocyclic system, or involved in a double bond.
Abstract:
The invention relates to substituted 1,4-benzothiazepine-1,1-dioxide derivatives and to the acid addition salts thereof. The invention discloses 1,4-benzothiazepine-1,1-dioxide derivatives of formula (I), wherein R , R , R and Z have the cited descriptions, the physiologically compatible salts thereof and physiologically functional derivatives, as well as methods for producing the same. The compounds are suited for use, e.g. as hypolipidemic agents.
Abstract:
Concomitant drugs for preventing or treating infection with gram-positive bacteria characterized in that at least one beta -lactam antimicrobial having an inhibitory effect on Staphylococcus and at least one antimicrobial selected from among tetracycline antimicrobials, quinolone antimicrobials, amino glycoside antimicrobials, macrolide antimicrobials and steroid antimicrobials are administered either simultaneously or separately at an interval.
Abstract:
The present invention relates to a palatable dosage form of a "jerky stick" or treat for companion animals which includes sea cucumber fractions alone or in combination with glucosamine sulfate and/or glucosamine hydrochloride, and/or sea vegetables, and/or green tea; such jerky stick containing an effective amount of sea cuccumber material for the inhibition or modulation or arthritic or nutritional problems in dogs or cats, and containing palatability co-factors which render the jerky stick attractive to the animal in need.
Abstract:
Disclosed are novel 1-galactose derivatives of formula (I) having a carbon- or nitrogen-containing aglycon linkage. The disclosed compounds inhibit binding of toxins, such as heat-labile enterotoxin or cholera toxin, to their receptors either in vitro or in vivo. The disclosed compounds also inhibit binding of enterovirulent organisms (e.g., bacteria, virus, fungi, and the like), such as Vibrio cholerae and enterotoxigenic strains of Escherichia coli, to their cell surface receptors.
Abstract:
The present invention relates to compositions for the protection, treatment and repair of connective tissues in humans and animals comprising any or all of anabolic, anti-catabolic, anti-oxidant and analgesic agents, including aminosugars, S-adenosylmethionine, arachadonic acid, GAGs, including pentosan, collagen type II, tetracyclines or tetracycline-like compounds, diacerin, super oxide dismutase, L-ergothionine, one or more avocado/soybean unsaponifiables, hydroxyproline and an analgesic, e.g., acetaminophen, and to methods of treating humans and animals by administration of these novel compositions to humans and animals in need thereof.
Abstract:
The present invention discloses a composition for topical use comprising a free sphingoid base and a ceramide. The compositions of the invention are suitable for application to skin conditions associated with an impaired barrier function, in particular to skin conditions further associated with a deranged regulation of cell growth and differentiation, an inflammatory condition and/or an infectious state.
Abstract:
The invention relates to the use of the disaccharide derivatives 3'-aminosaccharose, saccharose-C6-acid and palatinose-C6'-acid and/or an amide or alkylester thereof for preventing or treating hyperglycaemia.